THRY Thryv Holdings drops 518 after reporting Q4 2025 EPS that missed analyst estimates by over 200 percent Is Legacy LEGH stock risky to buy today Legacy reports 256 EPS miss vs analyst estimates Why Linkage LGCB deserves a spot in every portfolio Tick Down 20260503 Vertex Pharmaceuticals VRTX Positioned to Capture Material Share in the FastGrowing IgA Nephropathy Market Via Lead LateStage Asset Povetacicept